Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: PD-L1 Inhibition as ChecKpoint Immunotherapy for NeuroEndocrine Phenotype Prostate Cancer [Phase 2]
Phase 2 trial updating PD-L1 inhibition as checkpoint immunotherapy for neuroendocrine phenotype prostate cancer completed with results post…
-
CLINICAL_TRIALS trial_result · 2021-03-02Clinical Trial Update: Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer [Phase 3]
Phase 3 trial evaluating radiation therapy strategies with or without short-term androgen deprivation therapy for men with a rising PSA afte…
-
CLINICAL_TRIALS trial_result · 2021-03-02Clinical Trial Update: A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer [Phase 3]
Phase 3 study update for SHR3680 in hormone-sensitive prostate cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: Genomics in Michigan Impacting Observation or Radiation [NA]
A completed clinical trial from the University of Michigan Rogel Cancer Center assessing genomics-guided observation or radiation strategies…
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate Cancer [NA]
A completed clinical trial comparing intensity-modulated radiation therapy with and without decreased radiation dose to erectile tissue in s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer [Phase 3]
Phase 3 trial evaluating hormone therapy with or without docetaxel in metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer [Phase 3]
Phase 3 trial comparing triptorelin with/without flutamide plus external-beam radiation therapy versus external-beam radiation therapy alone…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate [Phase 2]
Phase 2 clinical trial investigating beta-adrenergic receptor blockade as a novel therapy for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Comparison of Radiation Therapy Regimens in Treating Patients With Localized Prostate Cancer [Phase 3]
Phase 3 clinical trial comparing radiation therapy regimens for localized prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: High Resolution PET-MRI Before Prostate Cancer HIFU [Phase 2]
Phase 2 trial update evaluating high-resolution PET-MRI before HIFU treatment for prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study of SHR3680 in Combination With Docetaxel in the Treatment of mCRPC [Phase 2]
Phase 2 trial update of SHR3680 in combination with docetaxel for metastatic prostate cancer (mCRPC).
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Dovitinib(TKI258) in Patients With Castration-resistant Prostate Cancer [Phase 2]
Phase 2 clinical trial of Dovitinib (TKI258) in patients with castration-resistant prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating the effect of GTx-758 on serum PSA and testosterone in men with prostate cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-12Clinical Trial Update: MSG Use With 18F-DCFPyL PET/CT Imaging [NA]
A completed clinical trial evaluating the use of monosodium glutamate (MSG) with 18F-DCFPyL PET/CT imaging in prostate cancer, with results …
-
CLINICAL_TRIALS trial_result · 2021-02-12Clinical Trial Update: Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial of rucaparib combined with nivolumab in prostate and endometrial cancer was terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: Prostate Cancer Screening in Men With Germline BRCA2 Mutations
Clinical trial update on prostate cancer screening in men with germline BRCA2 mutations; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: HDR Brachytherapy vs. LDR Brachytherapy Monotherapy in Localized Prostate Cancer [Phase 2]
A Phase 2 clinical trial comparing HDR brachytherapy to LDR brachytherapy as monotherapy for localized prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-08Clinical Trial Update: Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI [Phase 3]
Phase 3 trial update evaluating hybrid C11-Choline PET/MR and mpMRI for staging prostate cancer has completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-08Clinical Trial Update: Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate [Phase 2]
Phase 2 trial examining neoadjuvant abiraterone plus androgen deprivation therapy for intraductal carcinoma of the prostate.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: A Prospective Study on 18F-DCFPyL PET/CT Imaging in Biochemical Recurrence of Prostate Cancer [Phase 3]
Prospective Phase 3 trial evaluating 18F-DCFPyL PET/CT imaging in biochemical recurrence of prostate cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: A Study for Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate Gland [Phase 1, Phase 2]
A combined Phase 1/2 trial evaluating whether an escalated dose of radiation to focal cancerous areas, as opposed to uniform dosing througho…
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Immunization With NY-ESO-1 Protein Combined With CpG 7909 in Patients With Prostate Cancer [Phase 1]
Phase 1 trial evaluating NY-ESO-1 protein with CpG 7909 in prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-26Clinical Trial Update: Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM) [Phase 1]
Phase 1 trial evaluating safety and tolerability of an MVA-based vaccine expressing brachyury and T-cell costimulatory molecules (MVA-Brachy…
-
CLINICAL_TRIALS trial_result · 2021-01-26Clinical Trial Update: SHIP (Selinexor in Hormone Insensitive Prostate Cancer) [Phase 2]
Phase 2 trial SHIP investigating selinexor in hormone-insensitive prostate cancer was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation [Phase 3]
A Phase III trial studying intensity-modulated hypofractionated radiotherapy dose escalation in prostate cancer; results status is unknown i…